Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2004-04-27
2008-03-18
Zucker, Paul A. (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C516S075000
Reexamination Certificate
active
07345093
ABSTRACT:
This invention concerns novel methods of enhancing the solubility of a compound. Compositions prepared using such methods are also disclosed. Compositions prepared using the methods have various advantages over conventionally known compositions.
REFERENCES:
patent: 5415869 (1995-05-01), Straubinger et al.
patent: 5580575 (1996-12-01), Unger et al.
patent: 5653998 (1997-08-01), Hamann et al.
patent: 5684169 (1997-11-01), Hamada et al.
patent: 5795896 (1998-08-01), Lofroth et al.
patent: 5830865 (1998-11-01), Stjernfelt et al.
patent: 6096331 (2000-08-01), Desai et al.
patent: 6538020 (2003-03-01), Joshi-Hangal et al.
patent: 2006/0014699 (2006-01-01), Edman et al.
patent: 0249561 (1987-12-01), None
patent: 0670166 (1995-09-01), None
patent: 0923943 (1999-06-01), None
patent: 1151755 (2001-11-01), None
patent: WO 95/12385 (1995-05-01), None
patent: WO 97/20041 (1997-06-01), None
patent: WO 97/30695 (1997-08-01), None
patent: WO 99/04787 (1999-02-01), None
patent: WO 99/13914 (1999-03-01), None
patent: WO 99/45918 (1999-09-01), None
patent: WO 99/49848 (1999-10-01), None
patent: WO 00/00179 (2000-01-01), None
patent: WO 00/03753 (2000-01-01), None
patent: WO 00/40238 (2000-07-01), None
patent: WO 00/71163 (2000-11-01), None
patent: WO 01/01960 (2001-01-01), None
patent: WO 01/30448 (2001-05-01), None
patent: WO 01/87345 (2001-11-01), None
patent: WO 02/07712 (2002-01-01), None
patent: WO 02/43765 (2002-06-01), None
patent: WO 02/080883 (2002-10-01), None
patent: WO 03/033592 (2003-04-01), None
patent: WO 03/045357 (2003-06-01), None
Szelag et al, Colloids and Surfaces A: Physiochemical and Engineering Aspects, The Behavior of Modified Monoacylglycerol Emulsifiers in Emulsion Systems, 1999, 155 pp. 349-357.
Solomons, Organic Chemistry, 5th Edition, 1992, John Wiley & Sons, Inc., New York, pp. 1049-1052.
Thrombosis Research, The Direct Thrombin Inhibitor Melagatran and Its Oral Prodrug H 376/95: Intestinal Absorption Properties, Biochemical and Pharmacodynamic Effects, 2001, 101, pp. 171-181.
European Journal of Hospital Pharmacists, Advances in Anticoagulant Care for the Prevention of Venous Thromboembolic Events After Orthopaedic Surgery: A Pharmaceutical Perspective on Ximelagatran, a Novel Oral Direct Thrombin Inhibitor, 2004, (5), Scientific section, pp. 264-270.
Baedelmeijer et al.,Cancer Chemother. Pharmacol., 49: 119-125 (2002).
O'Reilly et al.,Int'l. J. of Pharmaceutics, 109(2): 147-154 (1994).
Pinnamaneni et al.,Pharmazie, 57(5): 291-300 (2002).
Augustine John G.
Isaacs Benjamin S.
Isaacs Indu J.
Nellaiappan Kaliappanadar
Formatech, Inc.
Jones Day
Zucker Paul A.
LandOfFree
Methods of enhancing solubility of compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of enhancing solubility of compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of enhancing solubility of compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3975199